Lantern Pharma Inc. Common Stock LTRN

$2.65 +0.76% at last close

Analyst Consensus

Recent Analyst Actions

DateFirmActionRatingPrice Target
2025-04-02
Lake StreetChad Messer
Initiates coverage on Buy $25
2024-04-25
HC Wainwright & Co.Emily Bodnar
Reiterates Neutral
2023-08-10
EF HuttonMichael King
Reiterates Buy $11
2023-06-26
EF HuttonMichael King
Maintains Buy $11
2023-05-25
EF HuttonMichael King
Assumes Buy $11
2023-05-18
HC Wainwright & Co.Michael King
Initiates coverage on Neutral
2023-03-21
EF HuttonMichael King
Reiterates Buy $11
2023-02-15
EF HuttonMichael King
Maintains Buy $11
2022-11-01
EF HuttonMichael King
Initiates coverage on Buy $11
2022-03-11
HC Wainwright & Co.Michael King
Maintains Buy $34 → $36
2021-11-02
HC Wainwright & Co.Michael King
Maintains Buy $32 → $34
2021-10-07
HC Wainwright & Co.Michael King
Initiates coverage on Buy $32
2020-07-28
Colliers Securities
Initiates coverage on Buy $24

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$2.65
Market Cap
$33.88 million
52-Week Range
$1.11 $5.74
Average Volume
118K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.